CapVest to acquire majority stake in STADA
Bain Capital and Cinven will each retain a minority stake, reflecting their ongoing confidence in STADA’s future growth
Bain Capital and Cinven will each retain a minority stake, reflecting their ongoing confidence in STADA’s future growth
All intellectual-property disputes related to the market entry of Alvotech’s AVT02 (adalimumab) in the U.S. and Europe are now resolved
Subscribe To Our Newsletter & Stay Updated